Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$268.64-0.48 (-0.18%)
Delayed quote: Sep 9, 2026, 10:35 AM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 9, 2026, 10:35 AM EDT
Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 8.63 is in line with its 5-year average of 8.52, around the middle of its 5-year range (5.59–13.88).
2.31% above its 12-month average of 8.43.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
8.63
EARNINGS PER SHARE (EPS) AVG TTM
8.43
EARNINGS PER SHARE (EPS) AVG 3Y
9.39
EARNINGS PER SHARE (EPS) AVG 5Y
8.52
EARNINGS PER SHARE (EPS) AVG 10Y
6.79
EARNINGS PER SHARE (EPS) AVG 15Y
5.57
EARNINGS PER SHARE (EPS) AVG 20Y
5.13
CURRENT VS TTM AVG
+2.31%
CURRENT VS 3Y AVG
-8.14%
CURRENT VS 5Y AVG
+1.33%
CURRENT VS 10Y AVG
+27.05%
CURRENT VS 15Y AVG
+54.96%
CURRENT VS 20Y AVG
+68.24%
Johnson & Johnson
Market Cap
$647.40B
Earnings Per Share (EPS)
8.63
TTM Avg
8.43
3Y Avg
9.39
5Y Avg
8.52
Market Cap
$364.58B
Earnings Per Share (EPS)
1.25
TTM Avg
7.03
3Y Avg
4.98
5Y Avg
4.65
Market Cap
$1.06T
Earnings Per Share (EPS)
29.80
TTM Avg
17.38
3Y Avg
11.79
5Y Avg
9.91
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | $647.40B | 8.63 | 8.43 | 9.39 | 8.52 |
| Pfizer Inc. (PFE)vs › | $158.76B | 0.76 | 1.39 | 2.19 | 2.39 |
| Merck & Co., Inc. (MRK)vs › | $364.58B | 1.25 | 7.03 | 4.98 | 4.65 |
| AbbVie Inc. (ABBV)vs › | $439.15B | 3.55 | 2.38 | 3.54 | 3.89 |
| Eli Lilly and Company (LLY)vs › | $1.06T | 29.80 | 17.38 | 11.79 | 9.91 |
| Bristol-Myers Squibb Company (BMY)vs › | $131.94B | 4.54 | -0.48 | 1.47 | 0.84 |
Trailing EPS (TTM)
$8.63
Forward EPS (Est.)
$11.58
P/E Ratio
31.2
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-28 | 11.03 |
| 2024-12-29 | 5.84 |
| 2023-12-31 | 13.88 |
| 2023-01-01 | 6.83 |
| 2022-01-02 | 7.93 |
| 2021-01-03 | 5.59 |
| 2019-12-31 | 5.74 |
| 2018-12-31 | 5.75 |
| 2017-12-31 | 0.48 |
| 2016-12-31 | 6.08 |
| 2015-12-31 | 5.57 |
| 2014-12-31 | 5.86 |
| 2013-12-31 | 4.90 |
| 2012-12-31 | 3.91 |
| 2011-12-31 | 3.54 |
| 2010-12-31 | 4.86 |
| 2009-12-31 | 4.45 |
| 2008-12-31 | 4.67 |
| 2007-12-31 | 3.67 |
| 2006-12-31 | 3.76 |
| 2005-12-31 | 3.38 |
| 2004-12-31 | 2.75 |
| 2003-12-31 | 2.42 |
| 2002-12-31 | 2.20 |
| 2001-12-31 | 1.87 |
| 2000-12-31 | 1.65 |
| 1999-12-31 | 1.43 |
| 1998-12-31 | 1.08 |
| 1997-12-31 | 1.24 |
| 1996-12-31 | 1.09 |
Reported annual fiscal-period values; no daily interpolation.